1. Martínez LA. Risk of negative results associated with proton pump inhibitors: review of electronic prescription in polymedicated patients. Farm comunitarios. 2017;9(2):39-45. doi: 10.5672/FC.2173-9218.(2017/Vol9).002.04.
2. Enríquez-Gutiérrez E, Hernández-Arroyo MJ, Sánchez-Martín E, Díaz-Madero A, Teijeiro-Bermejo MC, Sáez-Rodríguez E. What a family doctor should know about proton pump inhibitors. Med Gen Fam. 2018;7(4):154-8. doi: 10.24038/mgyf.2018.046
3. Sánchez-Cuén JA, Irineo-Cabrales AB, Bernal-Magaña G, Peraza-Garay Fde J. Inadequate prescription of chronic consumption of proton pump inhibitors in a hospital in Mexico. Cross-sectional study. Rev Esp Enferm Dig. 2013;105(3):131-6. doi: 10.4321/s1130-01082013000300003.
4. Ricart-Pena T, Lozano-Espinosa M, Martínez-Lerma E, Bueno-Macías S. [Use of proton pump inhibitors in primary care. Always right?]. Semergen. 2015;41(8):455-6. doi: 10.1016/j.semerg.2014.12.010.
5. López-Dóriga Bonnardeaux P, Neira Álvarez M, Mansilla Laguía S. [Proton bomb inhibitors: a study of the prescription in a functional recovery unit]. Rev Esp Geriatr Gerontol. 201;48(6):269-71. doi: 10.1016/j.regg.2013.07.004.
6. Raña-Garibay R. Adverse effects and failure to proton pump inhibitors (PPI). Rev Gastroenterol Mex. 2011;76(Supl. 1):49-52.
7. Khalili H, Huang ES, Jacobson BC, Camargo CA Jr, Feskanich D, Chan AT. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study. BMJ. 2012;344:e372. doi: 10.1136/bmj.e372.
8. Mostafa G, Sing RF, Matthews BD, Pratt BL, Norton HJ, Heniford BT. The economic benefit of practice guidelines for stress ulcer prophylaxis. Am Surg. 2002;68(2):146-50.